How are drugs approved? Part 1: The evolution of the food and drug administration

Journal of Psychosocial Nursing and Mental Health Services

Volumn 46, Issue 1, 2008, Pages 15-19

  Howland, Robert H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG; NON PRESCRIPTION DRUG;

ADDICTION; CLINICAL TRIAL; DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HUMAN; MARKETING; ORGANIZATION; ORGANIZATION AND MANAGEMENT; POSTMARKETING SURVEILLANCE; REVIEW; SAFETY; STANDARD; UNITED STATES;

CLINICAL TRIALS AS TOPIC; DEVICE APPROVAL; DRUG APPROVAL; DRUGS, INVESTIGATIONAL; DRUGS, NON-PRESCRIPTION; HEALTH CARE REFORM; HUMANS; MARKETING; ORGANIZATIONAL OBJECTIVES; PRODUCT SURVEILLANCE, POSTMARKETING; SAFETY MANAGEMENT; SUBSTANCE-RELATED DISORDERS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 40849139282     PISSN: 02793695     EISSN: None     Source Type: Journal    
DOI: 10.3928/02793695-20080101-06     Document Type: Article

References (16)

1. Blier, P. (2007). Generic medications: Another variable in the treatment of illnesses. Journal of Psychopharmacology, 21, 459-460.
2. Drazen, J.M., Morrissey, S., & Curfman, G.D. (2007). Open clinical trials. New England Journal of Medicine, 357, 1756-1757.
3. Frank, R.G. (2007). The ongoing regulation of generic drugs. New England Journal of Medicine, 357, 1993-1996.
4. Hollander, I. (2006). Viagra's rise above women's health issues: An analysis of the social and political influences on drug approvals in the United States and Japan. Social Science & Medicine, 62, 683-693.
5. Lipsky, M.S., & Sharp, L.K. (2001). From idea to market: The drug approval process. Journal of the American Board of Family Practice, 14, 362-367.
6. Miller, P. (2005). Role of pharmacoeconomic analysis in R&D decision making. PharmacoEconomics, 23, 1-12.
7. Rivas-Vazquez, R.A. (2002). Overview of the drug approval process. Professional Psychology, Research and Practice, 33, 502-506.
8. Schultz, W.B. (2007). Bolstering the FDA's drug-safety authority. New England Journal of Medicine, 357, 2217-2219.
9. Steinbrook, R. (2002). Testing medicines in children. New England Journal of Medicine, 347, 1462-1470.
10. Swann, J.P. (1998). The 1938 food, drug, and cosmetic act. In History of the FDA. Retrieved December 6, 2007, from http://www.fda.gov/oc/history/ historyoffda/section2.html
11. U.S. Food and Drug Administration. (n.d.). What FDA regulates. Retrieved December 6, 2007, from http://www.fda.gov/comments/regs.html
12. U.S. Food and Drug Administration. (2000). FDA finalizes rules for claims on dietary supplements. Retrieved December 11, 2007, from http://www.fda.gov/bbs/topics/ANSWERS/ANS00994.html
13. U.S. Food and Drug Administration. (2002). FDA modernization act of 1997 (FDA-MA). Retrieved December 6, 2007, from http://www.fda.gov/cdrh/ modact/modern.html
14. U.S. Food and Drug Administration. (2007). Law strengthens FDA. Retrieved December 10, 2007, from http://www.fda.gov/oc/initiatives/advance/ fdaaa.html
15. Welage, L.S., Kirking, D.M., Ascione, F.J., & Gaither, C.A. (2001). Understanding the scientific issues embedded in the generic drug approval process. Journal of the American Pharmaceutical Association, 41, 856-867.
16. Wood, A.J.J. (2006). A proposal for radical changes in the drug-approval process. New England Journal of Medicine, 355, 618-623.